Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 14,656 | 10,039 | 7,617 | 6,105 | 4,499 |
| Operating Income | -14,656 | -10,039 | -7,617 | -6,105 | -4,499 |
| Interest Expense | 905 | 902 | 398 | 0 | 0 |
| Other Income | 37 | 115 | 132 | 84 | 67 |
| Pre-tax Income | -15,524 | -10,826 | -7,883 | -6,021 | -4,432 |
| Net Income Continuous | -15,524 | -10,826 | -7,883 | -6,021 | -4,432 |
| Net Income | $-15,524 | $-10,826 | $-7,883 | $-6,021 | $-4,432 |
| EPS Basic Total Ops | -360.00 | -240.00 | -200.00 | -180.00 | -160.00 |
| EPS Basic Continuous Ops | -355.44 | -248.24 | -205.68 | -177.98 | -165.34 |
| EPS Diluted Total Ops | -360.00 | -240.00 | -200.00 | -180.00 | -160.00 |
| EPS Diluted Continuous Ops | -355.44 | -248.24 | -205.68 | -177.98 | -165.34 |
| EBITDA(a) | $-14,599 | $-9,993 | $-7,573 | $-6,063 | $-4,459 |